Belgium: Georges Rawadi appointed as CEO of Celyad Oncology

Celyad Oncology, a biotechnology company focused on innovative technologies for chimeric antigen receptor (CAR) T-cell therapies, has appointed Georges Rawadi as its new CEO. He takes up the position on April 17, 2023. Michel Lussier will continue to serve as Interim CEO until April 17. Rawadi has over 20 years of experience in pharma/biotech as…

You must be a HMI Subscriber to view this content.

Subscribe Now »